The first CPVT-associated variants were identified in 2001 in the gene encoding the cardiac ryanodine receptor (RYR2) in four of 12 probands presenting with typical CPVT in the absence of structural heart abnormalities [171]. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.